TABLE 2.
Spontaneous modifications in the gacS gene isolated from phase II sectors and phase II mutants of Pseudomonas sp. strain PCL1171
Origin | Mutation in gacS genea
|
Functional gene
|
Remarks | Affected GacS domain | ||
---|---|---|---|---|---|---|
Nucleotide | Amino acid | gacA | gacS | |||
Phase II Tn5luxAB mutantsb | ||||||
Wild-type phase I | − | − | + | + | No mutations | |
PCL1574 | cT899c-cG899c | L300-R300 | + | − | Point mutation | Phosphotransfer |
PCL1575 | C154aa-T154aa | Q52-stop | + | − | gacS mutation | Periplasmic loop |
PCL1575a | − | + | gacA mutation | |||
PCL1575b | C154aa-T154aa | Q52-stop | − | − | gacA and gacS mutations | Periplasmic loop |
PCL1576 | aA329c-aG329c | N110-S110 | + | − | Inverted repeat | Periplasmic loop |
115-bp inversion | N110-R147 (stop134) | Inversiond | ||||
Wild-type phase II sectorsc | ||||||
Sector 1 | 12-bp deletion | A54PL56 | NDe | − | Deletiond and point mutations | Periplasmic loop |
cT263t-cC263t | L88-P88 | |||||
gA1813g-gG1813g | Silent | |||||
Sector 3 | ND | ND | ND | − | gacS mutation | |
Sector 4 | C1981cg-T1981cg | P661-S661 | ND | − | Point mutation | Phosphotransfer |
Sector 9 | ct_caat-ctT309caat | L103-frameshift | ND | − | 1-bp insertiond | Periplasmic loop |
Sector 16 | tT2231a-tC2231a | L744-S744 | ND | − | Tandem repeat | Phosphotransfer |
307-bp deletion | Deletiond | |||||
ggC663-ggA663 | Silent | |||||
Sector 18 | cT182g-cC182g | L61-P61 | ND | − | Point mutations | Periplasmic loop |
gC1124c-gT1124c | A375-V375 | Phosphotransfer | ||||
Sector 5 | ND | + | gacA mutation | |||
Sector 2 | cT443g-cC443g | L148-P148 | ND | + | gacA mutation |
Numbers indicate positions in the wild-type gacS sequence.
The functional gacA/gacS component was determined by the introduction of pMP6562 (gacS) and pMP5565 (gacA). A plus sign indicates which component is functional; a minus sign indicates which component harbors mutations and is nonfunctional. In addition, strains PCL1565, PCL1568, and another eight phase II mutants had a functional gacA gene (gacS mutants), while PCL1564, PCL1573, PCL1566, PCL1568, and another eight phase II mutants had a functional gacA gene (gacS mutants), while PCL1564, PCL1573, PCL1566, PCL1567, and another nine phase II mutants had a functional gacS gene (gacA mutants).
The functional gacA/gacS component was determined by complementation of PCL1572 (gacS::Tn5luxAB) by the gacS gene isolated from a phase II sector. A plus sign indicates that a phase I morphology was restored in PCL1572; a minus sign indicates that a phase II morphology was maintained after introduction of the gacS gene. In addition, the gacS genes isolated from another five sectors did complement PCL1572 (gacS::Tn5luxAB), suggesting that mutation of the gacA gene was responsible for the phase II phenotype in these sectors.
See Fig. 1.
ND, not determined.